InsiderTrades

Astle Christopher

SEC CIK 1915257 · EDGAR

Buying vs selling by month open-market trades, last 46 months, ZYME
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
ZYMEZymeworks Inc.SVP, CFO 7,934 — $83.4K 82022-12-122024-01-05

Most active insiders at ZYME, 12 months

#InsiderTitleBoughtSold
1 Galbraith KennethCOB, CEO, Dir —$3.34M
2 Moore Paul AndrewCSO —$721.5K
3 Smith Jeffrey T LEVP, Chief Medical Off —$475.6K
4 Hollywood MarkEVP, COO —$138.7K
5 PATTERSON LEONE DEVP, Chief Bus, Fin Off ——

Astle Christopher made no open-market trades at ZYME in the last 12 months.

Transactions 8

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
D 2024-01-08 2024-01-05 ZYME Zymeworks Inc. Astle Christopher SVP, CFO M - OptEx $0.00 +10.5K 12.5K +526% $0
DM 2024-01-08 2024-01-05+ ZYME Zymeworks Inc. Astle Christopher SVP, CFO S - Sale+OE $10.79 -5,994 7,934 -43% -$64.7K
D 2023-12-11 2023-12-11 ZYME Zymeworks Inc. Astle Christopher SVP, CFO S - Sale+OE $9.13 -886 1,997 -31% -$8,089
D 2023-12-11 2023-12-11 ZYME Zymeworks Inc. Astle Christopher SVP, CFO M - OptEx $0.00 +1,550 2,883 +116% $0
DA 2022-12-23 2022-12-12 ZYME Zymeworks Inc. Astle Christopher SVP, CFO S - Sale+OE $6.01 -887 1,333 -40% -$5,331
DA 2022-12-23 2022-12-12 ZYME Zymeworks Inc. Astle Christopher SVP, CFO M - OptEx $0.00 +1,550 2,220 +231% $0
D 2022-12-14 2022-12-12 ZYME Zymeworks Inc. Astle Christopher SVP, CFO S - Sale+OE $6.01 -887 1,333 -40% -$5,331
D 2022-12-14 2022-12-12 ZYME Zymeworks Inc. Astle Christopher SVP, CFO M - OptEx $0.00 +1,550 2,220 +231% $0

Purchase Sale Sale after option exercise All abbreviations